Modulation of immune parameters in patients with metastatic renal-cell cancer receiving combination immunotherapy (IL-2, IFNα and autologous IL-2-activated lymphocytes)
Jan W. Gratama, Paul I. M. Schmitz, S. Hoo Goey, Cor H. J. Lamers, Gerrit Stoter, Reinder L. H. BolhuisVolume:
65
Year:
1996
Language:
english
Pages:
9
DOI:
10.1002/(sici)1097-0215(19960117)65:23.0.co;2-y
File:
PDF, 1.02 MB
english, 1996